Omar R. Sadruddin, MD currently serves as Santen’s Global Medical Director for the Surgical Glaucoma business. Dr. Sadruddin brings a deep knowledge of ophthalmic devices and pharmaceuticals, with over a decade of experience in leading global clinical strategies and product development from the pre-clinical stage to post-marketing. In his role as Santen’s Global Medical Director, Dr. Sadruddin drives global medical affairs strategy and manages relationships with global investigators for Santen’s surgical product portfolio. Dr. Sadruddin also ensures the appropriate dissemination of clinical and scientific information in a timely, ethical and customer-focused manner. Prior to joining Santen in 2017, Dr. Sadruddin served as Global Director, Clinical Development-Medical Affairs at Alcon Research Ltd., where he led teams in the planning and conduct of various clinical programs. Previously, he held several positions of progressive responsibility in clinical development at the Cardiovascular Division of St. Jude Medical in Plymouth, MN. Dr. Sadruddin received his medical degree (MD) from ASU School of Medicine. He has also earned an MBA from Liberty University. Among his many publications are several studies investigating the safety and efficacy of Santen’s MicroShunt glaucoma device.